Medical Condition News

RSS

Vitamin D deficiency could be linked to development of certain autoimmune lung diseases

A new study shows that vitamin D deficiency could be linked to the development and severity of certain autoimmune lung diseases.

4 Jan 2011

Mercator, Pepscan enter multi-program cancer research collaboration

Mercator Therapeutics, the first biopharmaceutical company to systematically use in vivo phage display technology to develop novel cancer drugs and Pepscan Therapeutics, a world leader in protein mimicry technologies for improved therapeutic peptides and anti-GPCR antibodies, today announced a multi-program research collaboration. The companies will collaborate to optimize Mercator's 'Homing Peptides' using Pepscan's proprietary CLIPS technology.

4 Jan 2011

Researchers report estrogen may increase movement of precancerous cells in oral cavity

Head and neck cancer is the sixth most common type of cancer and is on the rise in some demographic groups, including young women without any known risk factors. Now, researchers at Fox Chase Cancer Center report that estrogen may increase the movement of precancerous cells in the mouth and thus promote the spread of the disease within the oral cavity.

4 Jan 2011

Depression and diabetes linked to increased risk of death from heart disease in women

Depression and diabetes appear to be associated with a significantly increased risk of death from heart disease and risk of death from all causes over a six-year period for women, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

4 Jan 2011

Lyophilized amniotic membrane in strabismus surgery can cause severe fibrosis

Postoperative adhesions are a major complication in strabismus surgery. Amniotic membrane has been used in the hopes of preventing these adhesions by forming a biological barrier during healing. In an article in the December 2010 issue of the Journal of AAPOS, a team of researchers from Cairo University have discovered that the new approach may also have the opposite effect.

4 Jan 2011

Risk-adjusted TTR appears to improve anticoagulation control

Researchers from Boston University School of Medicine and the Bedford VA Medical Center believe that risk-adjusted percent time in therapeutic range should be used as part of an effort to improve anticoagulation control and thus improve patient outcomes.

4 Jan 2011

Genes determine susceptibility to depression

University of Michigan Health System researchers have found new evidence that our genes help determine our susceptibility to depression.

4 Jan 2011

Researchers identify new biological pathway that contribute to glaucoma

In a study published today in the Proceedings of the National Academy of Sciences, a team of researchers from the Kennedy Krieger Institute and four collaborating institutions, identified a new and unexpected biological pathway that appears to contribute to the development of glaucoma and its resulting vision loss.

4 Jan 2011

Fondation Leducq awards Penn Medicine researcher $6M grant for cardiovascular disease study

An international team of researchers led by Daniel J. Rader, MD, associate director of Penn Medicine's Institute for Translational Medicine and Therapeutics, has received a $6 million grant from the Paris-based Fondation Leducq to study the molecular genetics of atherosclerotic cardiovascular disease. The team's proposal, "Molecular Mechanisms of Novel Genes Associated with Plasma Lipids and Cardiovascular Disease," was selected to receive the award through the Fondation's Transatlantic Networks of Excellence Program.

4 Jan 2011

Study: Multitude of genes are linked to adult height

As much as 90 percent of variation in adult height may be caused by genetic inheritance, but a multitude of genes are involved. Most of these have yet to be discovered.

4 Jan 2011

New approach to Alzheimer’s care

Protocols and practices at an Arizona nursing home that allows patients with Alzheimer’s disease freedom to eat and sleep when they want makes appears to make them happier and easier to care for, the New York Times reports. Beatitudes, a ministry of the Church of the Beatitude, has also done away with restraints. Each patient is cared for according to his/her individual needs.

3 Jan 2011

Deceptive food labels lead to increased risk of deadly diseases

Did you know that when you pick up a product promoted as trans fat free, you may still be ingesting a significant amount of this potentially harmful substance? An article by Case Western Reserve University School of Medicine student Eric Brandt, published in the January/February 2011 issue of the American Journal of Health Promotion, reveals that misleading labeling practices can result in medically significant intake of harmful trans fat, despite what you read on Food and Drug Administration (FDA) approved labels.

3 Jan 2011

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).

3 Jan 2011

FDA grants orphan drug status for Senesco's SNS01-T in treatment of multiple myeloma

Senesco Technologies, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's lead drug candidate SNS01-T for treatment of multiple myeloma.

3 Jan 2011

FDA clears ACT's IND to treat AMD using hESC derived RPE cells

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to treat Dry Age-Related Macular Degeneration (AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

3 Jan 2011

Celera seeks FDA premarketing approval for KIF6 Genotyping Assay

Celera Corporation today announced that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration (FDA) for its KIF6 Genotyping Assay, a new molecular In Vitro diagnostic (IVD) test designed to detect a marker for risk of coronary heart disease (CHD) independent of traditional risk factors and aid clinical evaluation when statin treatment is being considered.

3 Jan 2011

Top-line results of TIGER-2 Phase 3 clinical trial for CF treatment

Inspire Pharmaceuticals, Inc. announced today the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis.

3 Jan 2011

People magazine features another Dr. Siegal's Cookie Diet success story

For the second time in three years, Dr. Siegal's Cookie Diet success stories are celebrated in People magazine's annual Half Their Size cover story. Marty and Grace Moorehead of Phoenix lost 182 and 51 pounds respectively by following celebrity weight-loss expert Dr. Sanford Siegal's 36 year old weight-loss regimen under the supervision of their own physicians. Marty Moorehead lost half of his 360 pounds and has kept the weight off for a year. The People article is online at http://tinyurl.com/2vl2apk.

3 Jan 2011

Teenage autistic boy allowed sex change procedure

A 16 year old autistic schoolboy has been granted approval to begin treatment for a sex change. He will have the provision to have his sperm frozen in case he decides he wants children. The decision came from Family Court judge Justice Linda Dessau on an emergency application from the boy’s parents so that he can begin therapy before his puberty fully sets in.

30 Dec 2010

New report evaluates rate of reinterventions, readmissions after initial AAA surgery

A new report published in the January issue of the Journal of Vascular Surgery® evaluates the rate of reinterventions and readmissions after initial abdominal aortic aneurysm repair, 30-day mortality and the effect on long-term survival.

30 Dec 2010

Medical Condition News

Vitamin D deficiency could be linked to development of certain autoimmune lung diseases

Mercator, Pepscan enter multi-program cancer research collaboration

Researchers report estrogen may increase movement of precancerous cells in oral cavity

Depression and diabetes linked to increased risk of death from heart disease in women

Lyophilized amniotic membrane in strabismus surgery can cause severe fibrosis

Risk-adjusted TTR appears to improve anticoagulation control

Genes determine susceptibility to depression

Researchers identify new biological pathway that contribute to glaucoma

Fondation Leducq awards Penn Medicine researcher $6M grant for cardiovascular disease study

Study: Multitude of genes are linked to adult height

New approach to Alzheimer’s care

Deceptive food labels lead to increased risk of deadly diseases

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

FDA grants orphan drug status for Senesco's SNS01-T in treatment of multiple myeloma

FDA clears ACT's IND to treat AMD using hESC derived RPE cells

Celera seeks FDA premarketing approval for KIF6 Genotyping Assay

Top-line results of TIGER-2 Phase 3 clinical trial for CF treatment

People magazine features another Dr. Siegal's Cookie Diet success story

Teenage autistic boy allowed sex change procedure

New report evaluates rate of reinterventions, readmissions after initial AAA surgery

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News